Dr Israel Paul Nosnik, MD | |
4001 W 15th St, Suite 300, Plano, TX 75093-5841 | |
(214) 750-0808 | |
Not Available |
Full Name | Dr Israel Paul Nosnik |
---|---|
Gender | Male |
Speciality | Urology - Pediatric Urology |
Location | 4001 W 15th St, Plano, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962660019 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2088P0231X | Urology - Pediatric Urology | 036129839 (Illinois) | Secondary |
2088P0231X | Urology - Pediatric Urology | Q0138 (Texas) | Primary |
Entity Name | Cook Childrens Physician Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750369203 PECOS PAC ID: 7719884584 Enrollment ID: O20040128000800 |
News Archive
Warning labels on junk food would be more effective than a "fat" tax for deterring overweight people from making unhealthy purchases, a new University of Alberta study has found.
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML).
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. today announced positive top-line results from Study WL1001-04-03, a Phase II clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide, a novel TRPV-1 receptor modulator in the treatment of post-herpetic neuralgia (PHN).
There is an ongoing debate regarding the relationship between knee osteoarthritis and hormone therapy, with small-scale studies providing mixed results.
New findings by researchers at UT Southwestern Medical Center suggest that serotonin a brain chemical known to help regulate emotion, mood and sleep might also have anti-diabetic properties.
› Verified 2 days ago
Entity Name | Dallas Physician Medical Services For Children Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194153650 PECOS PAC ID: 1759607906 Enrollment ID: O20150305000673 |
News Archive
Warning labels on junk food would be more effective than a "fat" tax for deterring overweight people from making unhealthy purchases, a new University of Alberta study has found.
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML).
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. today announced positive top-line results from Study WL1001-04-03, a Phase II clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide, a novel TRPV-1 receptor modulator in the treatment of post-herpetic neuralgia (PHN).
There is an ongoing debate regarding the relationship between knee osteoarthritis and hormone therapy, with small-scale studies providing mixed results.
New findings by researchers at UT Southwestern Medical Center suggest that serotonin a brain chemical known to help regulate emotion, mood and sleep might also have anti-diabetic properties.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Israel Paul Nosnik, MD Po Box 733784, Dallas, TX 75373-3784 Ph: (682) 885-1855 | Dr Israel Paul Nosnik, MD 4001 W 15th St, Suite 300, Plano, TX 75093-5841 Ph: (214) 750-0808 |
News Archive
Warning labels on junk food would be more effective than a "fat" tax for deterring overweight people from making unhealthy purchases, a new University of Alberta study has found.
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML).
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. today announced positive top-line results from Study WL1001-04-03, a Phase II clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide, a novel TRPV-1 receptor modulator in the treatment of post-herpetic neuralgia (PHN).
There is an ongoing debate regarding the relationship between knee osteoarthritis and hormone therapy, with small-scale studies providing mixed results.
New findings by researchers at UT Southwestern Medical Center suggest that serotonin a brain chemical known to help regulate emotion, mood and sleep might also have anti-diabetic properties.
› Verified 2 days ago
David H Ewalt, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4001 W 15th St Ste 300, Plano, TX 75093 Phone: 214-750-0808 Fax: 682-303-9572 | |
Meredith L Lightfoot, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 6124 W Parker Rd, Ste 434, Plano, TX 75093 Phone: 214-691-1902 Fax: 214-987-1845 | |
Mr. Stephen J Lieman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5300 W Plano Pkwy, Plano, TX 75093 Phone: 972-612-8037 Fax: 972-867-6049 | |
William R Strand, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4001 W 15th St, Suite 300, Plano, TX 75093 Phone: 214-750-0808 Fax: 214-750-0120 | |
Dr. Jeffrey Scott Hassell, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5300 W Plano Pkwy, Plano, TX 75093 Phone: 972-612-8037 Fax: 972-867-6049 | |
Michael G Wierschem, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5425 W Spring Creek Pkwy, Suite 150, Plano, TX 75024 Phone: 972-403-5425 Fax: 214-501-1252 | |
Dr. Vince J. Rogenes, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5300 W Plano Pkwy, Plano, TX 75093 Phone: 972-612-8037 Fax: 972-867-6049 |